Viewing Study NCT02287558


Ignite Creation Date: 2025-12-25 @ 12:20 AM
Ignite Modification Date: 2026-02-25 @ 4:15 AM
Study NCT ID: NCT02287558
Status: COMPLETED
Last Update Posted: 2020-07-15
First Post: 2014-11-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Sponsor: The Cleveland Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hereditary Hemorrhagic Telangiectasia View
None Idiopathic Vascular Ectasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HHT View
None CASE4Z14 View
None Pomalidomide View